# Servier Highlights Growing Neuro-Oncology Portfolio with New Data Across Pediatric and Adult Glioma at SNO 2026

- Source: PR Newswire M&A
- Published: 2026-11-06T13:00:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/servier-highlights-growing-neuro-oncology-portfolio-with-new-data-across-pediatric-and-adult-glioma-at-sno-2026-302932038.html
- Canonical: https://groundlevelnews.com/story/servier-highlights-growing-neuro-oncology-portfolio-with-new-data-acro-65ee06/

Updated results from the four-year follow-up analysis of the Phase 2 FIREFLY-1 study provide additional information on the duration of response to OJEMDA® (tovorafenib) in patients with relapsed or refractory BRAF-altered pediatric low-grade glioma Breadth of clinical and real-world data...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._